EXHIBIT G- CDC PRESS RELEASE LOWERING BLOOD LEAD REFERENCE IN CHILDREN

Home Browse Search

6/23/22, 10:26 AM CDC updates blood lead reference value | Lead | CDC https://www.cdc.gov/nceh/lead/news/cdc-updates-blood-lead-reference-value.html#:~:text=CDC updates blood lead reference value to 3.5 µg%2FdL&text=CDC uses a blood lead,higher than most children's levels.5/6 The primary dierence between a blood lead reference value of 3.5 µg/dL and 5 µg/dL is that children with blood lead levels within the 3.5–5 µg/dL range will also be prioritized for lead exposure reduction actions. Even low levels of lead in blood have been shown to aect a child’s intelligence, ability to pay attention, and academic achievement. Who will pay for the testing and interventions needed? (Follow up tests for children with lower levels)The blood lead reference value is based on a percentile of the population distribution of blood lead levels (BLLs). Because population growth has been relatively stable, the number of children with BLLs equal to or higher than 3.5 µg/dL today should be similar to the number of children with BLLs equal to or higher than 5 µg/dL in 2012. Therefore, overall national costs should not change much. Children can be given a blood test to measure the level of lead in their blood. These tests are covered by Medicaid and most private health insurance. Costs associated with additional recommended actions will vary based on individual factors (e.g., health insurance status, recommended intervention, programs available in the jurisdiction). If the child’s BLL is 3.5 µg/dL or higher, CDC recommends that the child be referred for a follow-up venous blood test to assess the next steps. More information on follow-up can be found at Recommended Actions Based on Blood Lead Level. What children should be tested? Or retested?CDC recommends targeted screening eorts to focus on children having sociodemographic risk factors and those living in housing built before 1978. Public health and clinical professionals should collaborate to develop screening plans responsive to local conditions using local data. Lacking such plans, universal blood lead testing is appropriate. Additionally, CDC recommends that jurisdictions follow the Centers for Medicare & Medicaid Services requirement that all Medicaid-enrolled children be tested at ages 12 months and 24 months, or at ages 24–72 months if not previously been screened. How does the blood lead reference value t in with CDC’s lead poisoning prevention eorts?CDC’s lead poisoning prevention eorts and the updated blood lead reference value (BLRV) align well with the Federal Lead Action Plan’s and CDC’s goals to reduce children’s exposure to lead. Updating the BLRV is a step in achieving health equity and environmental justice. The risk for lead exposure is not the same for all children. There are signicant disparities in health outcomes across racial and ethnic groups and people with dierent socioeconomic status. Higher blood lead levels are more prevalent among children from racial and ethnic minority groups, children from low-income households, and children who live in housing built before 1978. Also, children from racial and ethnic minority groups are more likely to live in conditions where there is greater likelihood of exposure. Some of these conditions include poor housing and environmental exposures, such as lead in air, soil, and water.  Additional Resources MMWR Policy Note: Update of the Blood Lead Reference Value — United States, 2021. Press Release: CDC Updates Blood Lead Reference Value for Children Recommended Actions Based on Conrmed Blood Lead Level